Her 2 positive Breast Cancer

What is HER2-Positive Breast Cancer?

HER2-Positive Breast Cancer is a type of breast cancer where cancer cells have an overexpression of the human epidermal growth factor receptor 2 (HER2) protein. HER2 promotes cell growth, and when it’s overproduced, it can cause cells to grow and divide more rapidly, contributing to the spread of cancer.

HER2-positive breast cancer is considered an aggressive form of breast cancer. However, targeted treatments have greatly improved outcomes for people with HER2-positive breast cancer.

Who is at Risk?

HER2-positive breast cancer can affect anyone, but factors that might increase the risk include:

  • Age – This type of breast cancer can appear at any age, though it’s more common in younger women.

  • Genetic Factors – Although rare, certain genetic mutations may increase the likelihood of developing HER2-positive breast cancer.

How is HER2-Positive Breast Cancer Diagnosed?

The diagnostic process includes:

  1. Breast Examination – Your healthcare provider checks for lumps or changes.

  2. Imaging Tests – Mammograms, ultrasounds, CTs or MRIs are used to examine the breast tissue.

  3. Biopsy – A small tissue sample is taken and tested to confirm the presence of HER2 proteins on cancer cells. The two common tests used to determine HER2 status are:

    • Immunohistochemistry (IHC) – Measures the amount of HER2 protein on cancer cells.

    • Fluorescence in situ hybridization (FISH) – Looks for extra copies of the HER2 gene in cancer cells.

Treatment Options for HER2-Positive Breast Cancer

There are several effective treatments specifically targeting HER2-positive breast cancer. These may be used alone or in combination, depending on the individual case.

1. Targeted Therapy

  • Trastuzumab (Herceptin) – A monoclonal antibody that targets HER2 proteins, blocking signals that cause cancer cells to grow.

  • Pertuzumab (Perjeta) – Often used alongside trastuzumab, especially for advanced HER2-positive breast cancer.

  • Ado-trastuzumab emtansine (Kadcyla) – A combination of trastuzumab and chemotherapy that targets HER2-positive cancer cells while delivering chemotherapy directly to them.

2. Chemotherapy

  • Chemotherapy is often combined with targeted therapies to kill rapidly dividing cancer cells and help prevent recurrence. It may be administered before (neoadjuvant) or after surgery (adjuvant).

3. Surgery

  • Lumpectomy – Removes only the tumour and a small margin of surrounding tissue.

  • Mastectomy +/- reconstruction – Removes one or both breasts if the cancer is more widespread.

  • Lymph Node Removal – Checks if the cancer has spread to nearby lymph nodes.

4. Radiation Therapy

  • Radiation may be recommended after surgery to kill any remaining cancer cells in the breast or chest area, reducing the chance of recurrence.

Managing Life with HER2-Positive Breast Cancer

Side Effects of Treatment: Side effects may include fatigue, nausea, heart-related issues, and hair loss. Your healthcare team can help manage these effects with supportive therapies.

Follow-up Care: Regular follow-up visits with your healthcare provider are essential to monitor for any signs of recurrence. Follow-up care often includes imaging, physical exams, and blood tests.

Lifestyle Support: Staying active, eating a nutritious diet, and practicing stress-relief techniques can help maintain physical and emotional health.

Support and Resources

HER2-positive breast cancer can be challenging, but support is available:

  • Support Groups – Local and online groups can connect you with others going through similar experiences.

  • Cancer Support Services – Hospitals often offer counseling, physical therapy, and nutrition support.

  • You will have a Breast Care Nurse as part of your journey through breast cancer treatment. Their role is to guide you through the maze of appointments and treatments, to be a source of emotional and physical support and your point of contact for questions and concerns now and in the future. 

Questions for Your Doctor

  • What stage is my HER2-positive breast cancer, and what does this mean?

  • What treatment options are best for my situation?

  • What are the potential side effects of treatment?

  • Are there clinical trials that could be beneficial?

Remember: Many people with HER2-positive breast cancer live full, healthy lives after treatment. Advances in targeted therapies have improved survival rates and quality of life for those with HER2-positive breast cancer.

Previous
Previous

Hormone Positive Breast Cancer

Next
Next

Triple Negative Breast Cancer